Sunrest Lifescience Board Meeting Outcome
Sunrest Lifescience Limited has cancelled its Rights Issue due to the non-receipt of the minimum subscription required by SEBI regulations.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
12 announcements with these filters
Sunrest Lifescience Limited has cancelled its Rights Issue due to the non-receipt of the minimum subscription required by SEBI regulations.
Sunrest Lifescience held its 9th AGM on 7 Sep 2026 via VC/OAVM. Resolutions covered adoption of FY26 financials, re-appointment of MD and WTD, and related-party transaction approval.
Sunrest Lifescience Limited has extended its ongoing Rights Issue by nine days, with the new closing date set for September 11, 2026.
Sunrest Lifescience Limited's subsidiary, Hetvi Lifesciences, is executing a ₹9.22 Crore order from Gujarat Medical Services Corporation Limited. ₹80.76 Lakhs worth of work is completed.
Sunrest Lifescience Limited has issued a notice for its Annual General Meeting scheduled for September 7, 2026, to transact various ordinary and special businesses.
Sunrest Lifescience Limited will hold its Annual General Meeting on September 07, 2026. The company has also filed its Annual Report for the financial year 2025-26.
Sunrest Lifescience's Board approved the 9th AGM notice and cut-off dates. The Board also approved director re-appointments and material related party transactions.
Sunrest Lifescience Limited has scheduled a board meeting for August 12, 2026. The meeting will address general business matters.
Sunrest Lifescience Limited has fixed August 10, 2026, as the record date for its 1:1 rights issue. Eligible shareholders will receive one equity share for every share held.
Sunrest Lifescience Limited announced a Rights Issue of 42,91,200 equity shares at Rs.35 per share, totaling Rs.15.02 Crore. The issue opens on August 18, 2026.
Sunrest Lifescience rescheduled its board meeting to July 30, 2026. The meeting's agenda includes a fund raise via rights issue.
Sunrest Lifescience rescheduled its board meeting to July 17, 2026. The meeting will consider a proposed rights issue for fund raising.